Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionARS Investment Partners, LLC
Latest Disclosed Ownership306,127 shares
Latest Disclosed Value $ 18,566,603
ARS Investment Partners, LLC reports 53.60% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 16, 2026 - ARS Investment Partners, LLC filed a 13F-HR form disclosing ownership of 306,127 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $16,047,177 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 199,301 shares of Bristol-Myers Squibb Company. This represents a change in shares of 53.60% during the quarter. The current value of the position is $14,519,604 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 306,127 106,826 53.60 18,567 72.71 0.9650
2026-02-05 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 199,301 177,916 831.97 10,750 1,015.15 0.6282
2025-10-15 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,385 -200 -0.93 964 -3.50 0.0637
2025-08-11 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,585 -100 -0.46 999 -18.52 0.0729
2025-05-14 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 21,685 0 0.00 1,227 0.00 0.1110
2025-01-16 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 21,685 500 2.36 1,227 11.86 0.1105
2024-10-16 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,185 -357 -1.66 1,096 22.60 0.0982
2024-07-17 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,542 -1,062 -4.70 895 -27.02 0.0856
2024-05-02 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 22,604 254 1.14 1,226 6.89 0.1221
2024-02-14 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 22,350 -1,525 -6.39 1,147 -17.26 0.1271
2023-11-13 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 23,875 -800 -3.24 1,386 -12.18 0.1718
2023-07-11 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 24,675 -516 -2.05 1,578 -9.63 0.1844
2023-04-05 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 25,191 1,735 7.40 1,746 3.44 0.2096
2023-01-25 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 23,456 -13,985 -37.35 1,688 -36.63 0.2245
2022-10-07 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 37,441 13,550 56.72 2,662 44.67 0.3660
2022-07-15 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 23,891 0 0.00 1,840 5.44 0.2514
2022-05-16 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 23,891 400 1.70 1,745 19.11 0.1682
2022-02-11 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 23,491 -1,870 -7.37 1,465 -2.40 0.1346
2021-11-05 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 25,361 0 0.00 1,501 -11.45 0.1502
2021-08-06 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 25,361 -36,959 -59.31 1,695 -56.91 0.1728
2021-05-13 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 62,320 -96 -0.15 3,934 1.60 0.4569
2021-02-09 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 62,416 266 0.43 3,872 3.34 0.4766
2020-11-12 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 62,150 1,529 2.52 3,747 5.11 0.5890
2020-08-13 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 60,621 30,548 101.58 3,565 112.71 0.6709
2020-05-12 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 30,073 -300 -0.99 1,676 -14.05 0.4046
2020-02-12 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 30,373 1,825 6.39 1,950 34.67 0.3277
2019-11-14 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 28,548 -15,270 -34.85 1,448 -27.13 0.2601
2019-08-12 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 43,818 10,032 29.69 1,987 23.26 0.3340
2019-05-09 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 33,786 -156,874 -82.28 1,612 -83.74 0.2918
2019-02-13 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 190,660 -12,441 -6.13 9,911 -21.40 2.0973
2018-11-13 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 203,101 1,709 0.85 12,609 13.14 1.9533
2018-11-13 2018-06-30 13F/A-1 BRISTOL MYERS SQUIBB COM 110122108 201,392 -27,434 -11.99 11,145 -22.99 1.7785
2018-08-13 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 201,392 -27,434 11,145
2018-05-04 2018-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 228,826 3,952 1.76 14,473 5.03 1.7727
2018-02-14 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 224,874 -1,400 -0.62 13,780 -4.46 1.6662
2017-11-14 2017-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 226,274 14,739 6.97 14,423 22.36 1.8581
2017-08-04 2017-06-30 13F BRISTOL MYERS SQUIBB CS 110122108 211,535 -1,094 -0.51 11,787 1.94 1.6283
2017-05-10 2017-03-31 13F BRISTOL MYERS SQUIBB CS 110122108 212,629 33,621 18.78 11,563 10.53 1.6804
2017-02-15 2016-12-31 13F BRISTOL MYERS SQUIBB CS 110122108 179,008 11,541 6.89 10,461 15.85 1.6103
2016-11-09 2016-09-30 13F Bristol-Myers Squibb COM 110122108 167,467 31 0.02 9,030 -26.67 1.9796
2016-08-10 2016-06-30 13F Bristol-Myers Squibb COM 110122108 167,436 -6,902 -3.96 12,315 10.58 2.7585
2016-05-11 2016-03-31 13F Bristol-Myers Squibb COM 110122108 174,338 -2,033 -1.15 11,137 -8.21 2.6100
2016-02-16 2015-12-31 13F Bristol-Myers Squibb COM 110122108 176,371 -6,893 -3.76 12,133 11.84 2.8488
2015-11-13 2015-09-30 13F Bristol-Myers Squibb COM 110122108 183,264 -2,948 -1.58 10,849 -12.44 2.4857
2015-08-11 2015-06-30 13F Bristol-Myers Squibb COM 110122108 186,212 -2,571 -1.36 12,391 1.76 2.2664
2015-05-13 2015-03-31 13F Bristol-Myers Squibb COM 110122108 188,783 -12,195 -6.07 12,177 2.64 2.2622
2015-02-13 2014-12-31 13F Bristol-Myers Squibb COM 110122108 200,978 -3,570 -1.75 11,864 13.33 2.0170
2014-11-12 2014-09-30 13F Bristol-Myers Squibb COM 110122108 204,548 1,305 0.64 10,469 6.19 1.5950
2014-07-30 2014-06-30 13F Bristol-Myers Squibb COM 110122108 203,243 -7,276 -3.46 9,859 -9.85 1.5265
2014-05-13 2014-03-31 13F Bristol-Myers Squibb COM 110122108 210,519 -26,739 -11.27 10,936 -13.28 1.9281
2014-02-11 2013-12-31 13F Bristol-Myers Squibb COM 110122108 237,258 -60,188 -20.23 12,610 -8.40 2.1171
2013-11-08 2013-09-30 13F Bristol-Myers Squibb COM 110122108 297,446 -29,234 -8.95 13,766 -5.71 2.3469
2013-08-14 2013-06-30 13F Bristol-Myers Squibb COM 110122108 326,680 326,680 14,599 2.5663
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.